| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |